# Odyssey Therapeutics Inc. (ODTX)

Source: https://www.quantisnow.com/company/ODTX
Generated: 2026-11-17T01:58:27.886Z

- Ticker: ODTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2026
- SEC CIK: 0001882782
- Website: https://odysseytx.com/

## About

Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of internally discovered and developed medicines with its first program advancing through multiple clinical milestones. Odyssey's portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the Company believes have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.

## Latest ODTX news and filings

- 2026-11-10 13:00 UTC [Odyssey Therapeutics Announces Publication Highlighting Differentiated Therapeutic Potential of TNFR2 Agonism](https://www.quantisnow.com/insight/odyssey-therapeutics-announces-publication-highlighting-differentiated-therapeutic-potential-of-tnfr2-6782929)
- 2026-11-06 12:35 UTC [Analyst Coverage Resumed] [H.C. Wainwright resumed coverage on Odyssey Therapeutics with a new price target](https://www.quantisnow.com/insight/hc-wainwright-resumed-coverage-on-odyssey-therapeutics-with-a-new-6778023)
- 2026-11-05 18:22 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Odyssey Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-odyssey-therapeutics-inc-6775596)
- 2026-11-04 12:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Odyssey Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-odyssey-therapeutics-inc-6771325)
- 2026-11-04 12:00 UTC [SEC Form 8-K] [Odyssey Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/odyssey-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6771240)
- 2026-11-04 12:00 UTC [Earnings] [Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/odyssey-therapeutics-reports-third-quarter-2026-financial-results-and-provides-6771209)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ODTX
- Earnings history: https://www.quantisnow.com/earnings/ODTX
- Dividend history: https://www.quantisnow.com/dividends/ODTX
- Insider transactions: https://www.quantisnow.com/insiders/ODTX
- Options chain: https://www.quantisnow.com/options/ODTX
- SEC 8-K filings only: https://www.quantisnow.com/company/ODTX/8-k
- RSS and alerts for ODTX: https://www.quantisnow.com/docs/rss-feeds.md
